$NRXP: NRx Pharmaceuticals Secures Early FDA Approval for Preservative-Free K

$NRXP

$NRXP – NRx Pharmaceuticals Secures Early FDA Approval for Preservative-Free Ketamine

NRX Pharmaceuticals, Inc.

2026-11-02 00:00:00 UTC · SEC_8K · All $NRXP

?? Positive AI Sentiment (+7.5 / 10)

FDA grants approval for NRXP's preservative-free Ketamine presentation ahead of the Nov 10 goal date.
The product addresses ongoing Ketamine shortages and eliminates benzethonium chloride (BZT).
High commercial catalyst for the micro-cap biotech firm.